Laboratory Values
18.5.10 Laboratory Values
In JAMA and the Archives Journals, laboratory values for clinical chemistry analyses, hematologic tests, immunologic assays, metabolic and endocrine tests, therapeutic drug monitoring, toxicology determinations, and urinalysis are reported by means of conventional laboratory units. Table 2 provides examples of conventional units and SI units for clinical laboratory measurement and is intended to facilitate conversion from conventional units to SI units (and vice versa). However, laboratory reference values and units may vary substantially among individual laboratories and are highly dependent on the analytic methods used. Several resources4-8 contain detailed information about these topics as well as tables with laboratory reference values and SI conversion factors.
Table 2. Selected Laboratory Tests, With Reference Ranges and Conversion Factorsa
Analyte |
Specimen |
Reference Range, Conventional Unit |
Conventional Unit |
Conversion Factor (Multiply by) |
Reference Range, SI Unit |
SI Unit |
|---|---|---|---|---|---|---|
Acetaminophen |
Serum, plasma |
10-30 |
μg/mL |
6.614 |
66-200 |
μmol/L |
Acetoacetate |
Serum, plasma |
< 1 |
mg/dL |
97.95 |
< 100 |
μmol/L |
Acetone |
Serum, plasma |
< 1.0 |
mg/dL |
0.172 |
< 0.17 |
mmol/L |
Acid phosphatase |
Serum |
< 5.5 |
U/L |
16.667 |
< 90 |
nkat/L |
Activated partial thromboplastin time (APTT) |
Whole blood |
25-40 |
s |
1.0 |
25-40 |
s |
Adenosine deaminase |
Serum |
11.5-25.0 |
U/L |
16.667 |
190-420 |
nkat/L |
Adrenocorticotropic hormone (ACTH) |
Plasma |
< 120 |
pg/mL |
0.22 |
< 26 |
pmol/L |
Alanine |
Plasma |
1.87-5.89 |
mg/dL |
112.2 |
210-661 |
μmol/L |
Alanine aminotransferase (ALT) |
Serum |
10-40 |
U/L |
0.0167 |
0.17-0.68 |
μkat/L |
Albumin |
Serum |
3.5-5.0 |
g/dL |
10 |
35-50 |
g/L |
Alcohol dehydrogenase |
Serum |
< 2.8 |
U/L |
16.667 |
< 47 |
nkat/L |
Aldolase |
Serum |
1.0-7.5 |
U/L |
0.0167 |
0.02-0.13 |
μkat/L |
Aldosterone |
Serum, plasma |
2-9 |
ng/dL |
27.74 |
55-250 |
pmol/L |
Alkaline phosphatase |
Serum |
30-120 |
U/L |
0.0167 |
0.5-2.0 |
μkat/L |
Alprazolam |
Serum, plasma |
10-50 |
ng/mL |
3.24 |
32-162 |
nmol/L |
Amikacin |
Serum, plasma |
20-30 |
μg/mL |
1.708 |
34-52 |
μmol/L |
α-Aminobutyric acid |
Plasma |
0.08-0.36 |
mg/dL |
96.97 |
8-35 |
μmol/L |
δ-Aminolevulinic acid |
Serum |
15-23 |
μg/dL |
0.0763 |
1.1-8.0 |
μmol/L |
Amiodarone |
Serum, plasma |
0.5-2.5 |
μg/mL |
1.55 |
0.8-3.9 |
μmol/L |
Amitriptyline |
Plasma |
120-250 |
ng/mL |
3.605 |
433-903 |
nmol/L |
Ammonia (as nitrogen) |
Serum, plasma |
15-45 |
μg/dL |
0.714 |
11-32 |
μmol/L |
Amobarbital |
Serum |
1-5 |
μg/mL |
4.42 |
4-22 |
μmol/L |
Amphetamine |
Serum, plasma |
20-30 |
ng/mL |
7.4 |
148-222 |
nmol/L |
Amylase |
Serum |
27-131 |
U/L |
0.0167 |
0.46-2.23 |
μkat/L |
Androstenedione |
Serum |
75-205 |
ng/dL |
0.0349 |
2.6-7.2 |
nmol/L |
Angiotensin I |
Plasma |
< 25 |
pg/mL |
0.772 |
< 15 |
pmol/L |
Angiotensin II |
Plasma |
10-60 |
pg/mL |
0.957 |
0.96-58 |
pmol/L |
Angiotensin-converting enzyme |
Serum |
< 40 |
U/L |
16.667 |
< 670 |
nkat/L |
Anion gap Na+− (Cl− + HCO3−) |
Serum, plasma |
8-16 |
mEq/L |
1.0 |
8-16 |
mmol/L |
Antidiuretic hormone (ADH) |
Plasma |
1-5 |
pg/mL |
0.923 |
0.9-4.6 |
pmol/L |
Antithrombin III |
Plasma |
21-30 |
mg/dL |
10 |
210-300 |
mg/L |
α1-Antitrypsin |
Serum |
78-200 |
mg/dL |
0.184 |
14.5-36.5 |
μmol/L |
Apolipoprotein A-I |
Serum |
80-151 |
mg/dL |
0.01 |
0.8-1.5 |
g/L |
Apolipoprotein B |
Serum, plasma |
50-123 |
mg/dL |
0.01 |
0.5-1.2 |
g/L |
Arginine |
Serum |
0.37-2.40 |
mg/dL |
57.05 |
21-138 |
μmol/L |
Arsenic |
Whole blood |
< 2-23 |
μg/L |
0.0133 |
0.03-0.31 |
μmol/L |
Ascorbic acid (see Vitamin C) |
||||||
Asparagine |
Plasma |
0.40-0.91 |
mg/dL |
75.689 |
30-69 |
μmol/L |
Aspartate aminotransferase (AST) |
Serum |
10-30 |
U/L |
0.0167 |
0.17-0.51 |
μkat/L |
Aspartic acid |
Plasma |
< 0.3 |
mg/dL |
75.13 |
< 25 |
μmol/L |
Atrial natriuretic hormone |
Plasma |
20-77 |
pg/mL |
0.325 |
6.5-2.5 |
pmol/L |
Bands (see White blood cell count) |
||||||
Basophils (see White blood cell count) |
||||||
Base excess |
Whole blood |
−2 to 3 |
mEg/L |
1.0 |
− 2 to 3 |
mmol/L |
Bicarbonate |
Serum |
21-28 |
mEq/L |
1.0 |
21-28 |
mmol/L |
Bile acids (total) |
Serum |
0.3-2.3 |
μg/mL |
2.448 |
0.73-5.63 |
μmol/L |
Bilirubin, total |
Serum |
0.3-1.2 |
mg/dL |
17.104 |
5.0-21.0 |
μmol/L |
Bilirubin, direct (conjugated) |
Serum |
0.1-0.3 |
mg/dL |
17.104 |
1.7-5.1 |
μmol/L |
Biotin |
Serum |
200-500 |
pg/mL |
0.00409 |
0.82-2.05 |
nmol/L |
Bismuth |
Whole blood |
1-12 |
μg/L |
4.785 |
4.8-57.4 |
nmol/L |
Blood gases |
||||||
Carbon dioxide, Pco2 |
Arterial blood |
35-45 |
mm Hg |
0.133 |
4.7-5.9 |
kPa |
pH |
Arterial blood |
7.35-7.45 |
1.0 |
7.35-7.45 |
||
Oxygen, Po2 |
Arterial blood |
80-100 |
mm Hg |
0.133 |
11-13 |
kPa |
Brain-type natriuretic peptide (BNP) |
Plasma |
< 167 |
pg/mL |
1.0 |
< 167 |
ng/L |
Bromide (toxic) |
Serum |
> 1250 |
μg/mL |
0.0125 |
> 15.6 |
mmol/L |
C1 esterase inhibitor |
Serum |
12-30 |
mg/dL |
10 |
120-300 |
mg/L |
C3 complement |
Serum |
1200-1500 |
μg/mL |
0.001 |
1.2-1.5 |
g/L |
C4 complement |
Serum |
350-600 |
μg/mL |
0.001 |
0.35-0.60 |
g/L |
Cadmium |
Whole blood |
0.3-1.2 |
μg/L |
8.896 |
2.7-10.7 |
nmol/L |
Caffeine |
Serum, plasma |
3-15 |
μg/L |
0.515 |
2.5-7.5 |
μmol/L |
Calcitonin |
Plasma |
3-26 |
pg/mL |
0.292 |
0.8-7.6 |
pmol/L |
Calcium, ionized |
Serum |
4.60-5.08 |
mg/dL |
0.25 |
1.15-1.27 |
mmol/L |
Calcium, total |
Serum |
8.2-10.2 |
mg/dL |
0.25 |
2.05-2.55 |
mmol/L |
Cancer antigen (CA) 125 |
Serum |
< 35 |
U/mL |
1.0 |
< 35 |
kU/L |
Carbamazepine |
Serum, plasma |
8-12 |
μg/mL |
4.233 |
34-51 |
μmol/L |
Carbon dioxide (total) |
Serum, plasma |
22-28 |
mEq/L |
1.0 |
22-28 |
mmol/L |
Carboxyhemoglobin, toxic |
Whole blood |
> 20 |
% |
0.01 |
> 0.2 |
Proportion of 1.0 |
Carcinoembryonic antigen (CEA) |
Serum |
< 3.0 |
ng/mL |
1.0 |
< 3.0 |
μg/L |
β-Carotene |
Serum |
10-85 |
μg/dL |
0.01863 |
0.2-1.6 |
μmol/L |
Carotenoids |
Serum |
50-300 |
μg/dL |
0.01863 |
0.9-5.6 |
μmol/L |
Ceruloplasmin |
Serum |
20-40 |
mg/dL |
10 |
200-400 |
mg/L |
Chloramphenicol |
Serum |
10-25 |
μg/mL |
3.095 |
31-77 |
μmol/L |
Chlordiazepoxide |
Serum, plasma |
0.4-3.0 |
μg/mL |
3.336 |
1.3-10.0 |
μmol/L |
Chloride |
Serum, plasma |
96-106 |
mEq/L |
1.0 |
96-106 |
mmol/L |
Chlorpromazine |
Plasma |
50-300 |
ng/mL |
3.126 |
157-942 |
nmol/L |
Chlorpropamide |
Plasma |
75-250 |
mg/L |
3.61 |
270-900 |
μmol/L |
Cholecalciferol (see Vitamin D) |
||||||
Cholesterol (total) |
||||||
Desirable |
Serum, plasma |
< 200 |
mg/dL |
0.0259 |
< 5.18 |
mmol/L |
Borderline high |
Serum, plasma |
200-239 |
mg/dL |
0.0259 |
5.18-6.18 |
mmol/L |
High |
Serum, plasma |
≥240 |
mg/dL |
0.0259 |
≥6.21 |
mmol/L |
Cholesterol, high-density (HDL) (low level) |
Serum, plasma |
< 40 |
mg/dL |
0.0259 |
< 1.03 |
mmol/L |
Cholesterol, low-density (LDL) (high level) |
Serum, plasma |
> 160 |
mg/dL |
0.0259 |
4.144 |
mmol/L |
Cholinesterase |
Serum |
5-12 |
mg/L |
2.793 |
14-39 |
nmol/L |
Chorionic gonadotropin (β-hCG) (nonpregnant) |
Serum |
5.0 |
mIU/mL |
1.0 |
5.0 |
IU/L |
Chromium |
Whole blood |
0.7-28.0 |
μg/L |
19.232 |
13.4-538.6 |
nmol/L |
Citrate |
Serum |
1.2-3.0 |
mg/dL |
52.05 |
60-160 |
μmol/L |
Citrulline |
Plasma |
0.2-1.0 |
mg/dL |
57.081 |
12-55 |
μmol/L |
Clonazepam |
Serum |
10-50 |
ng/mL |
0.317 |
0.4-15.8 |
nmol/L |
Clonidine |
Serum, plasma |
1.0-2.0 |
ng/mL |
4.35 |
4.4-8.7 |
nmol/L |
Clozapine |
Serum |
200-350 |
ng/mL |
0.003 |
0.6-1.0 |
μmol/L |
Coagulation factor I |
Plasma |
0.15-0.35 |
g/dL |
29.41 |
4.4-10.3 |
μmol/L |
(Fibrinogen) |
Plasma |
150-350 |
mg/dL |
0.01 |
1.5-3.5 |
g/L |
Coagulation factor II (prothrombin) |
Plasma |
70-130 |
% |
0.01 |
0.70-1.30 |
Proportion of 1.0 |
Coagulation factor V |
Plasma |
70-130 |
% |
0.01 |
0.70-1.30 |
Proportion of 1.0 |
Coagulation factor VII |
Plasma |
60-140 |
% |
0.01 |
0.60-1.40 |
Proportion of 1.0 |
Coagulation factor VIII |
Plasma |
50-200 |
% |
0.01 |
0.50-2.00 |
Proportion of 1.0 |
Coagulation factor IX |
Plasma |
70-130 |
% |
0.01 |
0.70-1.30 |
Proportion of 1.0 |
Coagulation factor X |
Plasma |
70-130 |
% |
0.01 |
0.70-1.30 |
Proportion of 1.0 |
Coagulation factor XI |
Plasma |
70-130 |
% |
0.01 |
0.70-1.30 |
Proportion of 1.0 |
Coagulation factor XII |
Plasma |
70-130 |
% |
0.01 |
0.70-1.30 |
Proportion of 1.0 |
Cobalt |
Serum |
4.0-10.0 |
μg/L |
16.968 |
67.9-169.7 |
nmol/L |
Cocaine (toxic) |
Serum |
> 1000 |
ng/mL |
3.297 |
> 3300 |
nmol/L |
Codeine |
Serum |
10-100 |
ng/mL |
3.34 |
33-334 |
nmol/L |
Coenzyme Q10 (ubiquinone) |
Plasma |
0.5-1.5 |
μg/mL |
1.0 |
0.5-1.5 |
mg/L |
Copper |
Serum |
70-140 |
μg/dL |
0.157 |
11-22 |
μmol/L |
Coproporphyrin |
Urine |
< 200 |
μg/24 h |
1.527 |
< 300 |
μmol/d |
Corticotropin |
Plasma |
< 120 |
pg/mL |
0.22 |
< 26 |
pmol/L |
Cortisol |
Serum, plasma |
5-25 |
μg/dL |
27.588 |
140-690 |
nmol/L |
Cotinine |
Plasma |
0-8 |
μg/L |
5.675 |
0-45 |
nmol/L |
C-peptide |
Serum |
0.5-2.5 |
ng/mL |
0.331 |
0.17-0.83 |
nmol/L |
C-reactive protein |
Serum |
0.08-3.1 |
mg/L |
9.524 |
0.76-28.5 |
nmol/L |
Creatine |
Serum |
0.1-0.4 |
mg/dL |
76.25 |
8-31 |
μmol/L |
Creatine kinase (CK) |
Serum |
40-150 |
U/L |
0.0167 |
0.67-2.5 |
μkat/L |
Creatine kinase–MB fraction |
Serum |
0-7 |
ng/mL |
1.0 |
0-7 |
μg/L |
Creatinine |
Serum, plasma |
0.6-1.2 |
mg/dL |
88.4 |
53-106 |
μmol/L |
Creatinine clearance |
Serum, plasma |
75-125 |
mL/min/1.73 m2 |
0.0167 |
1.24-2.08 |
mL/s/m2 |
Cyanide (toxic) |
Whole blood |
> 1.0 |
μg/mL |
23.24 |
> 23 |
μmol/L |
Cyclic adenosine monophosphate (cAMP) |
Plasma |
4.6-8.6 |
ng/mL |
3.04 |
14-26 |
μmol/L |
Cyclosporine |
Serum |
100-400 |
ng/mL |
0.832 |
83-333 |
nmol/L |
Cystine |
Plasma |
0.40-1.40 |
mg/dL |
41.615 |
16-60 |
μmol/L |
D-dimer |
Plasma |
< 0.5 |
μg/mL |
5.476 |
< 3.0 |
nmol/L |
Dehydroepiandrosterone (DHEA) |
Serum |
1.8-12.5 |
ng/mL |
3.47 |
6.2-43.3 |
nmol/L |
Dehydroepiandrosterone sulfate (DHEA-S) |
Serum |
50-450 |
μg/dL |
0.027 |
1.6-12.2 |
μmol/L |
Deoxycorticosterone |
Serum |
2-19 |
ng/dL |
30.5 |
61-576 |
nmol/L |
Desipramine |
Serum, plasma |
50-200 ng/mL |
3.754 |
170-700 |
nmol/L |
|
Diazepam |
Serum, plasma |
100-1000 |
ng/mL |
0.0035 |
0.35-3.51 |
μmol/L |
Digoxin |
Plasma |
0.5-2.0 |
ng/mL |
1.281 |
0.6-2.6 |
nmol/L |
Diltiazem |
Serum |
< 200 |
mg/L |
2.412 |
< 480 |
μmol/L |
Disopyramide |
Serum, plasma |
2.8-7.0 |
μg/mL |
2.946 |
8.3-22.0 |
μmol/L |
Dopamine |
Plasma |
< 87 |
pg/mL |
6.528 |
< 475 |
pmol/L |
Doxepin |
Serum, plasma |
30-150 |
ng/mL |
3.579 |
108-538 |
nmol/L |
Electrophoresis (protein) |
||||||
Proportion of total protein |
||||||
Albumin |
Serum |
52-65 |
% |
0.01 |
0.52-0.65 |
Proportion of 1.0 |
α1-Globulin |
Serum |
2.5-5.0 |
% |
0.01 |
0.025-0.05 |
Proportion of 1.0 |
α2-Globulin |
Serum |
7.0-13.0 |
% |
0.01 |
0.07-0.13 |
Proportion of 1.0 |
β-Globulin |
Serum |
8.0-14.0 |
% |
0.01 |
0.08-0.14 |
Proportion of 1.0 |
γ-Globulin |
Serum |
12.0-22.0 |
% |
0.01 |
0.12-0.22 |
Proportion of 1.0 |
Concentration |
||||||
Albumin |
Serum |
3.2-5.6 |
g/dL |
10.0 |
32-56 |
g/L |
α1-Globulin |
Serum |
0.1-0.4 |
g/dL |
10.0 |
1-10 |
g/L |
α2-Globulin |
Serum |
0.4-1.2 |
g/dL |
10.0 |
4-12 |
g/L |
β-Globulin |
Serum |
0.5-1.1 |
g/dL |
10.0 |
5-11 |
g/L |
γ-Globulin |
Serum |
0.5-1.6 |
g/dL |
10.0 |
5-16 |
g/L |
Eosinophils (see White blood cell count) |
||||||
Ephedrine (toxic) |
Serum |
> 2 |
μg/mL |
6.052 |
> 12.1 |
μmol/L |
Epinephrine |
Plasma |
< 60 |
pg/mL |
5.459 |
< 330 |
pmol/L |
Erythrocyte count (see Red blood cell count) |
||||||
Erythrocyte sedimentation rate |
Whole blood |
0-20 |
mm/h |
1.0 |
0-20 |
mm/h |
Erythropoietin |
Serum |
5-36 |
IU/L |
1.0 |
5-36 |
IU/L |
Estradiol (E2) |
Serum |
30-400 |
pg/mL |
3.671 |
110-1470 |
pmol/L |
Estriol (E3) |
Serum |
5-40 |
ng/mL |
3.467 |
17.4-138.8 |
nmol/L |
Estrogens (total) |
Serum |
60-400 |
pg/mL |
1.0 |
60-400 |
ng/L |
Estrone (E1) |
Serum, plasma |
1.5-25.0 |
pg/mL |
3.698 |
5.5-92.5 |
pmol/L |
Ethanol (ethyl alcohol) |
Serum, whole blood |
< 20 |
mg/dL |
0.2171 |
< 4.3 |
mmol/L |
Ethchlorvynol (toxic) |
Serum, plasma |
> 20 |
μg/mL |
6.915 |
> 138 |
μmol/L |
Ethosuximide |
Serum |
40-100 |
mg/L |
7.084 |
280-700 |
μmol/L |
Ethylene glycol (toxic) |
Serum, plasma |
> 30 |
mg/dL |
0.1611 |
> 5 |
mmol/L |
Fatty acids (nonesterified) |
Serum, plasma |
8-25 |
mg/dL |
0.0355 |
0.28-0.89 |
mmol/L |
Fecal fat (as stearic acid) |
Stool |
2.0-6.0 |
g/d |
1.0 |
2-6 |
g/24 h |
Fenfluramine |
Serum |
0.04-0.30 |
μg/mL |
4.324 |
0.18-1.30 |
μmol/L |
Fentanyl |
Serum |
0.01-0.10 |
μg/mL |
2.972 |
0.02-0.30 |
μmol/L |
Ferritin |
Serum |
15-200 |
ng/mL |
2.247 |
33-450 |
pmol/Lng/mL |
α1-Fetoprotein |
Serum |
< 10 |
ng/mL |
1.0 |
< 10 |
μg/L |
Fibrin degradation products |
Plasma |
< 10 |
μg/mL |
1.0 |
< 10 |
mg/L |
Fibrinogen |
Plasma |
200-400 |
mg/dL |
0.0294 |
5.8-11.8 |
μmol/L |
Flecanide |
Serum, plasma |
0.2-1.0 |
μg/mL |
2.413 |
0.5-2.4 |
μmol/L |
Fluoride |
Whole blood |
< 0.05 |
mg/dL |
0.5263 |
< 0.027 |
mmol/L |
Fluoxetine |
Serum |
200-1100 |
ng/mL |
0.00323 |
0.65-3.56 |
μmol/L |
Flurazepam (toxic) |
Serum, plasma |
> 0.2 |
μg/mL |
2.5 |
> 0.5 |
μmol/L |
Folate (folic acid) |
Serum |
3-16 |
ng/mL |
2.266 |
7-36 |
nmol/L |
Follicle-stimulating hormone (FSH) |
Serum, plasma |
1-100 |
mIU/mL |
1.0 |
1-100 |
IU/L |
Fructosamine |
Serum |
36-50 |
mg/L |
5.581 |
200-280 |
mmol/L |
Fructose |
Serum |
1-6 |
mg/dL |
55.506 |
55-335 |
μmol/L |
Galactose |
Serum, plasma |
< 20 |
mg/dL |
0.0555 |
< 1.10 |
mmol/L |
Gastrin |
Serum |
25-90 |
pg/mL |
0.481 |
12-45 |
pmol/L |
Gentamicin |
Serum |
6-10 |
μg/mL |
2.090 |
12-21 |
μmol/L |
Glucagon |
Plasma |
20-100 |
pg/mL |
1.0 |
20-100 |
ng/L |
Glucose |
Serum |
70-110 |
mg/dL |
0.0555 |
3.9-6.1 |
mmol/L |
Glucose-6-phosphate dehydrogenase |
Whole blood |
10-14 |
U/g hemoglobin |
0.0167 |
0.17-0.24 |
nkat/g hemoglobin |
Glutamic acid |
Plasma |
0.2-2.8 |
mg/dL |
67.967 |
15-190 |
μmol/L |
Glutamine |
Plasma |
6.1-10.2 |
mg/dL |
68.423 |
420-700 |
μmol/L |
γ-Glutamyltransferase (GGT) |
Serum |
2-30 |
U/L |
0.0167 |
0.03-0.51 |
μkat/L |
Glutethimide |
Serum |
2-6 |
μg/mL |
4.603 |
9-28 |
μmol/L |
Glycerol (free) |
Serum |
0.3-1.72 |
mg/dL |
0.1086 |
0.32-0.187 |
mmol/L |
Glycine |
Plasma |
0.9-4.2 |
mg/dL |
133.2 |
120-560 |
μmol/L |
Gold |
Serum |
< 10 |
μg/dL |
50.770 |
< 500 |
nmol/L |
Growth hormone (GH) |
Serum |
0-18 |
ng/mL |
1.0 |
0-18 |
μg/L |
Haloperidol |
Serum, Plasma |
6-24 |
ng/mL |
2.66 |
16-65 |
nmol/L |
Haptoglobin |
Serum |
26-185 |
mg/dL |
10 |
260-1850 |
mg/L |
Hematocrit |
Whole blood |
41-50 |
% |
0.01 |
0.41-0.50 |
Proportion of 1.0 |
Hemoglobin |
Whole blood |
14.0-17.5 |
g/dL |
10.0 |
140-175 |
g/L |
Mean corpuscular hemoglobin (MCH) |
Whole blood |
26-34 |
pg/cell |
1.0 |
26-34 |
pg/cell |
Mean corpuscular hemoglobin concentration (MCHC) |
Whole blood |
33-37 |
g/dL |
10 |
330-370 |
g/L |
Mean corpuscular volume (MCV) |
Whole blood |
80-100 |
μm3 |
1.0 |
80-100 |
fL |
Hemoglobin A1c (glycated hemoglobin) |
Whole blood |
4-7 |
% of total hemoglobin |
0.01 |
0.04-0.07 |
Proportion of total hemoglobin |
Hemoglobin A2 |
Whole blood |
2.0-3.0 |
% |
0.01 |
0.02-0.03 |
Proportion of 1.0 |
Histamine |
Plasma |
0.5-1.0 |
μg/L |
8.997 |
4.5-9.0 |
nmol/L |
Histidine |
Plasma |
0.5-1.7 |
mg/dL |
64.45 |
32-110 |
μmol/L |
Homocysteine |
Plasma |
0.68-2.02 |
mg/L |
7.397 |
5-15 |
μmol/L |
Homovanillic acid |
Urine |
1.4-8.8 |
mg/24 h |
5.489 |
8-48 |
μmol/d |
Hydrocodone |
Serum |
< 0.02 |
μg/mL |
3.34 |
< 0.06 |
μmol/L |
Hydromorphone |
Serum |
0.008-0.032 |
μg/mL |
3504 |
28-112 |
nmol/L |
β-Hydroxybutyric acid |
Plasma |
< 3.0 |
mg/dL |
96.06 |
< 300 |
μmol/L |
5-Hydroxyindoleacetic acid (5-HIAA) |
Urine |
2-6 |
mg/24 h |
5.23 |
10.4-31.2 |
μmol/d |
Hydroxyproline |
Plasma |
< 0.55 |
mg/dL |
76.266 |
< 42 |
μmol/L |
Ibuprofen |
Serum |
10-50 |
μg/mL |
4.848 |
50-243 |
μmol/L |
Imipramine |
Plasma |
150-250 |
ng/mL |
3.566 |
536-893 |
nmol/L |
Immunoglobulin A (IgA) |
Serum |
40-350 |
mg/dL |
10 |
400-3500 |
mg/L |
Immunoglobulin D (IgD) |
Serum |
0-8 |
mg/dL |
10 |
0-80 |
mg/L |
Immunoglobulin E (IgE) |
Serum |
0-1500 |
μg/L |
0.001 |
0-1.5 |
mg/L |
Immunoglobulin G (IgG) |
Serum |
650-1600 |
mg/dL |
0.01 |
6.5-16.0 |
g/L |
Immunoglobulin M (IgM) |
Serum |
54-300 |
mg/dL |
10 |
550-3000 |
mg/L |
Insulin |
Serum |
2.0-20 |
μIU/mL |
6.945 |
14-140 |
pmol/L |
Insulinlike growth factor |
Serum |
130-450 |
ng/mL |
0.131 |
18-60 |
nmol/L |
Iodine |
Serum |
58-77 |
μg/L |
7.880 |
450-580 |
nmol/L |
Iron |
Serum |
60-150 |
μg/dL |
0.179 |
10.7-26.9 |
μmol/L |
Iron-binding capacity |
Serum |
250-450 |
μg/dL |
0.179 |
44.8-80.6 |
μmol/L |
Isoleucine |
Plasma |
0.5-1.3 |
mg/dL |
76.236 |
40-100 |
μmol/L |
Isoniazid |
Plasma |
1-7 |
μg/mL |
7.291 |
7-51 |
μmol/L |
Isopropanol (toxic) |
Serum, plasma |
> 400 |
mg/L |
0.0166 |
> 6.64 |
mmol/L |
Kanamycin |
Serum, plasma |
25-35 |
μg/mL |
2.08 |
52-72 |
μmol/L |
Ketamine |
Serum |
0.2-6.3 |
μg/mL |
4.206 |
0.8-26 |
μmol/L |
17-Ketosteroids |
Urine |
3-12 |
mg/24 h |
3.33 |
10-42 |
μmol/d |
Lactate |
Plasma |
5.0-15 |
mg/dL |
0.111 |
0.6-1.7 |
mmol/L |
Lactate dehydrogenase (LDH) |
Serum |
100-200 |
U/L |
0.0167 |
1.7-3.4 |
μkat/L |
LDH isoenzymes |
||||||
LD1 |
Serum |
17-27 |
% |
0.01 |
0.17-0.27 |
Proportion of 1.0 |
LD2 |
Serum |
27-37 |
% |
0.01 |
0.27-0.37 |
Proportion of 1.0 |
LD3 |
Serum |
18-25 |
% |
0.01 |
0.18-0.25 |
Proportion of 1.0 |
LD4 |
Serum |
3-8 |
% |
0.01 |
0.03-0.08 |
Proportion of 1.0 |
LD5 |
Serum |
0-5 |
% |
0.01 |
0-0.05 |
Proportion of 1.0 |
Lead |
Serum |
< 10-20 |
μg/dL |
0.0483 |
< 0.5-1.0 |
μmol/L |
Leucine |
Plasma |
1.0-2.3 |
mg/dL |
76.237 |
75-175 |
μmol/L |
Leukocytes (see White blood cell count) |
||||||
Lidocaine |
Serum, plasma |
1.5-6.0 |
μg/mL |
4.267 |
6.4-25.6 |
μmol/L |
Lipase |
Serum |
31-186 |
U/L |
0.0167 |
0.5-3.2 |
μkat/L |
Lipoprotein(a) [Lp(a)] |
Serum |
10-30 |
mg/dL |
0.0357 |
0.35-1.0 |
μmol/L |
Lithium |
Serum |
0.6-1.2 |
mEq/L |
1.0 |
0.6-1.2 |
mmol/L |
Lorazepam |
Serum |
50-240 |
ng/mL |
3.114 |
156-746 |
nmol/L |
Luteinizing hormone (LH) |
Serum, plasma |
1-104 |
mIU/mL |
1.0 |
1-104 |
IU/L |
Lycopene |
Serum |
0.15-0.25 |
mg/L |
1.863 |
0.28-0.46 |
μmol/L |
Lymphocytes (see White blood cell count) |
||||||
Lysergic acid diethylamide |
Serum |
< 0.004 |
μg/mL |
3726 |
< 15 |
nmol/L |
Lysine |
Plasma |
1.2-3.5 |
mg/dL |
68.404 |
80-240 |
μmol/L |
Lysozyme |
Serum, plasma |
0.4-1.3 |
mg/dL |
10 |
4-13 |
mg/L |
Magnesium |
Serum |
1.3-2.1 |
mEq/L |
0.50 |
0.65-1.05 |
mmol/L |
Manganese |
Whole blood |
10-12 |
μg/L |
18.202 |
182-218 |
nmol/L |
Maprotiline |
Plasma |
200-600 |
ng/mL |
1.0 |
200-600 |
μg/L |
Melatonin |
Serum |
10-15 |
ng/L |
4.305 |
45-66 |
pmol/L |
Meperidine |
Serum, plasma |
400-700 |
ng/mL |
4.043 |
1620-2830 |
nmol/L |
Mercury |
Serum |
< 5 |
μg/L |
4.985 |
< 25 |
nmol/L |
Metanephrine (total) |
Urine |
< 1.0 |
mg/24 h |
5.07 |
< 5 |
μmol/d |
Metformin |
Serum |
1-4 |
μg/mL |
7.742 |
8-30 |
μmol/L |
Methadone |
Serum, plasma |
100-400 |
ng/mL |
0.00323 |
0.32-1.29 |
μmol/L |
Methamphetamine |
Serum |
0.01-0.05 |
μg/mL |
6.7 |
0.07-0.34 |
μmol/L |
Methanol |
Plasma |
< 200 |
μg/mL |
0.0312 |
< 6.2 |
mmol/L |
Methaqualone |
Serum, plasma |
2-3 |
μg/mL |
4.0 |
8-12 |
μmol/L |
Methemoglobin |
Whole blood |
< 0.24 |
g/dL |
155 |
< 37.2 |
μmol/L |
Methemoglobin |
Whole blood |
< 1.0 |
% of total hemoglobin |
0.01 |
< 0.01 |
Proportion of total hemoglobin |
Methicillin |
Serum |
8-25 |
mg/L |
2.636 |
22-66 |
μmol/L |
Methionine |
Plasma |
0.1-0.6 |
mg/dL |
67.02 |
6-40 |
μmol/L |
Methotrexate |
Serum, plasma |
0.04-0.36 |
mg/L |
2200 |
90-790 |
nmol/L |
Methyldopa |
Plasma |
1-5 |
μg/mL |
4.735 |
5.0-25 |
μmol/L |
Metoprolol |
Serum, plasma |
75-200 |
ng/mL |
3.74 |
281-748 |
nmol/L |
β2-Microglobulin |
Serum |
1.2-2.8 |
mg/L |
1.0 |
1.2-2.8 |
mg/L |
Morphine |
Serum, plasma |
10-80 |
ng/mL |
3.504 |
35-280 |
nmol/L |
Myoglobin |
Serum |
19-92 |
μg/L |
0.0571 |
1.0-5.3 |
nmol/L |
Naproxen |
Serum |
26-70 |
μg/mL |
4.343 |
115-300 |
μmol/L |
Niacin (nicotinic acid) |
Urine |
2.4-6.4 |
mg/24 h |
7.30 |
17.5-46.7 |
μmol/d |
Nickel |
Whole blood |
1.0-28.0 |
μg/L |
17.033 |
17-476 |
nmol/L |
Nicotine |
Plasma |
0.01-0.05 |
mg/L |
6.164 |
0.062-0.308 |
μmol/L |
Nitrogen (nonprotein) |
Serum |
20-35 |
mg/dL |
0.714 |
14.3-25.0 |
mmol/L |
Nitroprusside (as thiocyanate) |
6-29 |
μg/mL |
17.2 |
103-500 |
μmol/L |
|
Norepinephrine |
Plasma |
110-410 |
pg/mL |
5.911 |
650-2423 |
pmol/L |
Nortriptyline |
Serum, plasma |
50-150 |
ng/mL |
3.797 |
190-570 |
nmol/L |
Ornithine |
Plasma |
0.4-1.4 |
mg/dL |
75.666 |
30-106 |
μmol/L |
Osmolality |
Serum |
275-295 |
mOsm/kg |
1.0 |
275-295 |
mmol/kg |
Osteocalcin |
Serum |
3.0-13.0 |
ng/mL |
1.0 |
3.0-13.0 |
μg/L |
Oxalate |
Serum |
1.0-2.4 |
mg/mL |
11.107 |
11-27 |
μmol/L |
Oxazepam |
Serum, plasma |
0.2-1.4 |
μg/mL |
3.487 |
0.7-4.9 |
μmol/L |
Oxycodone |
Serum |
10-100 |
ng/mL |
3.171 |
32-317 |
nmol/L |
Oxygen, partial pressure (Po2) |
Arterial blood |
80-100 |
mm Hg |
0.133 |
11-13 |
kPa |
Paraquat |
Whole blood |
0.1-1.6 |
μg/mL |
5.369 |
0.5-8.5 |
μmol/L |
Parathyroid hormone |
Serum |
10-65 |
pg/mL |
1 |
10-65 |
ng/L |
Pentobarbital |
Serum, plasma |
1-5 |
μg/mL |
4.439 |
4.0-22 |
μmol/L |
Pepsinogen |
Serum |
28-100 |
ng/mL |
1.0 |
28-100 |
μg/L |
pH (see Blood gases) |
||||||
Phencyclidine (toxic) |
Serum, plasma |
90-800 |
ng/mL |
4.109 |
370-3288 |
nmol/L |
Phenobarbital |
Serum, plasma |
15-40 |
μg/mL |
4.31 |
65-172 |
μmol/L |
Phenylalanine |
Plasma |
0.6-1.5 |
mg/dL |
60.544 |
35-90 |
μmol/L |
Phenylpropanolamine |
Serum |
0.05-0.10 |
μg/mL |
6613 |
330-660 |
nmol/L |
Phenytoin |
Serum, plasma |
10-20 |
mg/L |
3.968 |
40-79 |
μmol/L |
Phosphorus (inorganic) |
Serum |
2.3-4.7 |
mg/dL |
0.323 |
0.74-1.52 |
mmol/L |
Placental lactogen |
Serum |
0.5-1.1 |
μg/mL |
46.296 |
23-509 |
nmol/L |
Plasminogen (antigenic) |
Plasma |
10-20 |
mg/dL |
0.113 |
1.1-2.2 |
μmol/L |
Plasminogen activator inhibitor |
Plasma |
4-40 |
ng/mL |
19.231 |
75-750 |
pmol/L |
Platelet count (thrombocytes) |
Whole blood |
150-350 |
×103/μL |
1.0 |
150-350 |
×109/L |
Porphyrins (total) |
Urine |
20-120 |
μg/L |
1.203 |
25-144 |
nmol/L |
Potassium |
Serum |
3.5-5.0 |
mEq/L |
1.0 |
3.5-5.0 |
mmol/L |
Prealbumin |
Serum |
19.5-35.8 |
mg/dL |
10 |
195-358 |
mg/L |
Pregnanediol |
Urine |
< 2.6 |
mg/24 h |
3.12 |
< 8 |
μmol/d |
Pregnanetriol |
Urine |
< 2.5 |
mg/24 h |
2.972 |
< 7.5 |
μmol/d |
Primidone |
Serum, plasma |
5-12 |
μg/mL |
4.582 |
23-55 |
μmol/L |
Procainamide |
Serum, plasma |
4-10 |
μg/mL |
4.25 |
17-42 |
μmol/L |
Progesterone |
Serum |
0.15-25 |
ng/mL |
3.18 |
0.5-79.5 |
nmol/L |
Prolactin |
Serum |
3.8-23.2 |
μg/L |
43.478 |
90-140 |
pmol/L |
Proline |
Plasma |
1.2-3.9 |
mg/dL |
86.858 |
104-340 |
μmol/L |
Propoxyphene |
Plasma |
0.1-0.4 |
μg/mL |
2.946 |
0.3-1.2 |
μmol/L |
Propranolol |
Serum |
50-100 |
ng/mL |
3.856 |
193-386 |
nmol/L |
Prostate-specific antigen |
Serum |
< 4.0 |
ng/mL |
1.0 |
< 4.0 |
μg/L |
Protein (total) |
Serum |
6.0-8.0 |
g/dL |
10.0 |
60-80 |
g/L |
Prothrombin time (PT) |
Plasma |
10-13 |
s |
1.0 |
10-13 |
s |
Protoporphyrin |
Red blood cells |
15-50 |
μg/dL |
0.0178 |
0.27-0.89 |
μmol/L |
Protriptyline |
Serum, plasma |
70-250 |
μg/dL |
3.787 |
266-950 |
nmol/L |
Pyridoxine (see Vitamin B6) |
||||||
Pyruvate |
Plasma |
0.5-1.5 |
mg/dL |
113.56 |
60-170 |
μmol/L |
Quinidine |
Serum |
2.0-5.0 |
μg/mL |
3.082 |
6.2-15.4 |
μmol/L |
Red blood cell count |
Whole blood |
3.9-5.5 |
×106/μL |
1.0 |
3.9-5.5 |
×1012/L |
Renin |
Plasma |
30-40 |
pg/mL |
0.0237 |
0.7-1.0 |
pmol/L |
Reticulocyte count |
Whole blood |
25-75 |
×103/μL |
1.0 |
25-75 |
×109/L |
Reticulocyte count |
Whole blood |
0.5-1.5 |
% of red blood cells |
0.01 |
0.005-0.015 |
Proportion of red blood cells |
Retinol (see Vitamin A) |
||||||
Riboflavin (see Vitamin B2) |
||||||
Rifampin |
Serum |
4-40 |
mg/L |
1.215 |
5-49 |
μmol/L |
Salicylates |
Serum, plasma |
150-300 |
μg/mL |
0.0724 |
1086-2172 |
μmol/L |
Selenium |
Serum, plasma |
58-234 |
μg/L |
0.0127 |
0.74-2.97 |
μmol/L |
Serine |
Plasma |
0.7-2.0 |
mg/dL |
95.156 |
65-193 |
μmol/L |
Serotonin (5-hydroxytryptamine) |
Whole blood |
50-200 |
ng/mL |
0.00568 |
0.28-1.14 |
μmol/L |
Sex hormone–binding globulin |
Serum |
1.5-2.0 |
μg/mL |
8.896 |
13-17 |
nmol/L |
Sodium |
Serum |
136-142 |
mEq/L |
1.0 |
136-142 |
mmol/L |
Somatomedin C (Insulinlike growth factor) |
Serum |
130-450 |
ng/mL |
0.131 |
18-60 |
nmol/L |
Somatostatin |
Plasma |
< 25 |
pg/mL |
0.6110 |
< 15 |
pmol/L |
Streptomycin |
Serum |
7-50 |
mg/L |
1.719 |
12-86 |
μmol/L |
Strychnine |
Whole blood |
< 0.5 |
mg/L |
2.99 |
< 1.5 |
μmol/L |
Substance P |
Plasma |
< 240 |
pg/mL |
0.742 |
< 180 |
pmol/L |
Sulfate |
Serum |
10-32 |
mg/L |
31.188 |
310-990 |
μmol/L |
Sulfmethemoglobin |
Whole blood |
< 1.0 |
% of total hemoglobin |
0.01 |
< 0.010 |
Proportion of total hemoglobin |
Taurine |
Plasma |
0.3-2.1 |
mg/dL |
79.91 |
24-168 |
μmol/L |
Testosterone |
Serum |
300-1200 |
ng/dL |
0.0347 |
10.4-41.6 |
nmol/L |
Tetrahydrocannabinol |
Serum |
< 0.20 |
μg/mL |
3.180 |
< 0.60 |
μmol/L |
Theophylline |
Serum, plasma |
10-20 |
μg/mL |
5.55 |
56-111 |
μmol/L |
Thiamine (see Vitamin B1) |
||||||
Thiopental |
Serum, plasma |
1-5 |
μg/mL |
4.144 |
4.1-20.7 |
μmol/L |
Thioridazine |
Serum, plasma |
1.0-1.5 |
μg/mL |
2.699 |
2.7-4.1 |
μmol/L |
Threonine |
Plasma |
0.9-2.5 |
mg/dL |
84 |
75-210 |
μmol/L |
Thrombin time |
Plasma |
16-24 |
s |
1.0 |
16.24 |
s |
Thrombocytes (see Platelet count) |
||||||
Thyroglobulin |
Serum |
3-42 |
ng/mL |
1.0 |
3-42 |
μg/L |
Thyroid-stimulating hormone (TSH) |
Serum |
0.4-4.2 |
mIU/L |
1.0 |
0.4-4.2 |
mIU/L |
Thyroxine, free (FT4) |
Serum |
0.9-2.3 |
ng/dL |
12.871 |
12-30 |
pmol/L |
Thyroxine, total (T4) |
Serum |
5.5-12.5 |
μg/dL |
12.871 |
71-160 |
nmol/L |
Thyroxine-binding globulin |
Serum |
16.0-24.0 |
μg/mL |
17.094 |
206-309 |
nmol/L |
Tissue plasminogen activator |
Plasma |
< 0.04 |
IU/mL |
1000 |
< 40 |
IU/L |
Tobramycin |
Serum, plasma |
5-10 |
μg/mL |
2.139 |
10-21 |
μmol/L |
Tocainide |
Serum |
4-10 |
μg/mL |
5.201 |
21-52 |
μmol/L |
α-Tocopherol (see Vitamin E) |
||||||
Tolbutamide |
Serum |
80-240 |
μg/mL |
3.70 |
296-888 |
μmol/L |
Transferrin |
Serum |
200-400 |
mg/dL |
0.0123 |
2.5-5.0 |
μmol/L |
Triglycerides |
Serum |
< 160 |
mg/dL |
0.0113 |
1.8 |
mmol/L |
Triiodothyronine, free (FT3) |
Serum |
130-450 |
pg/dL |
0.0154 |
2.0-7.0 |
pmol/L |
Triiodothyronine, total (T3) |
Serum |
60-180 |
ng/dL |
0.0154 |
0.92-2.76 |
nmol/L |
Troponin I |
Serum |
0-0.4 |
ng/mL |
1.0 |
0-0.4 |
μg/L |
Troponin T |
Serum |
0-0.1 |
ng/mL |
1.0 |
0-0.1 |
μg/L |
Tryptophan |
Plasma |
0.5-1.5 |
mg/dL |
48.967 |
25-73 |
μmol/L |
Tyrosine |
Plasma |
0.4-1.6 |
mg/dL |
55.19 |
20-90 |
μmol/L |
Urea nitrogen |
Serum |
8-23 |
mg/dL |
0.357 |
2.9-8.2 |
mmol/L |
Uric acid |
Serum |
4.0-8.0 |
mg/dL |
59.485 |
240-480 |
μmol/L |
Urobilinogen |
Urine |
1-3.5 |
mg/24 h |
1.7 |
1.7-5.9 |
μmol/d |
Valine |
Plasma |
1.7-3.7 |
mg/dL |
85.361 |
145-315 |
μmol/L |
Valproic acid |
Serum, plasma |
50-100 |
μg/mL |
6.934 |
346-693 |
μmol/L |
Vancomycin |
Serum, plasma |
20-40 |
μg/mL |
0.690 |
14-28 |
μmol/L |
Vanillylmandelic acid (VMA) |
Urine |
2.1-7.6 |
mg/24 h |
5.046 |
11-38 |
μmol/d |
Vasoactive intestinal polypeptide |
Plasma |
< 50 |
pg/mL |
0.2960 |
< 15 |
pmol/L |
Vasopressin |
Plasma |
1.5-2.0 |
pg/mL |
0.923 |
1.0-2.0 |
pmol/L |
Verapamil |
Serum, Plasma |
100-500 |
ng/mL |
2.20 |
220-1100 |
nmol/L |
Vitamin A (retinol) |
Serum |
30-80 |
μg/dL |
0.0349 |
1.05-2.80 |
μmol/L |
Vitamin B1 (thiamine) |
Serum |
0-2 |
μg/dL |
29.6 |
0-75 |
nmol/L |
Vitamin B2 (riboflavin) |
Serum |
4-24 |
μg/dL |
26.6 |
106-638 |
nmol/L |
Vitamin B3 |
Whole blood |
0.2-1.8 |
μg/mL |
4.56 |
0.9-8.2 |
μmol/L |
Vitamin B6 (pyridoxine) |
Plasma |
5-30 |
ng/mL |
4.046 |
20-121 |
nmol/L |
Vitamin B12 |
Serum |
160-950 |
pg/mL |
0.7378 |
118-701 |
pmol/L |
Vitamin C (ascorbic acid) |
Serum |
0.4-1.5 |
mg/dL |
56.78 |
23-85 |
μmol/L |
Vitamin D (1,25 dihydroxyvitamin D) |
Serum |
25-45 |
pg/mL |
2.6 |
60-108 |
pmol/L |
Vitamin D (25-hydroxyvitamin D) |
Plasma |
14-60 |
ng/mL |
2.496 |
35-150 |
nmol/L |
Vitamin E (a-tocopherol) |
Serum |
5-18 |
μg/mL |
23.22 |
12-42 |
μmol/L |
Vitamin K |
Serum |
0.13-1.19 |
ng/mL |
2.22 |
0.29-2.64 |
nmol/L |
Warfarin |
Serum, plasma |
1.0-10 |
μg/mL |
3.247 |
3.2-32.4 |
μmol/L |
White blood cell count |
Whole blood |
4500-11 000 |
/μL |
0.001 |
4.5-11.0 |
×109/L |
Differential count |
||||||
Neutrophils-segmented |
Whole blood |
1800-7800 |
/μL |
0.001 |
1.8-7.8 |
×109/L |
Neutrophils-bands |
Whole blood |
0-700 |
/μL |
0.001 |
0-0.70 |
×109/L |
Lymphocytes |
Whole blood |
1000-4800 |
/μL |
0.001 |
1.0-4.8 |
×109/L |
Monocytes |
Whole blood |
0-800 |
/μL |
0.001 |
0-0.80 |
×109/L |
Eosinophils |
Whole blood |
0-450 |
/μL |
0.001 |
0-0.45 |
×109/L |
Basophils |
Whole blood |
0-200 |
/μL |
0.001 |
0-0.20 |
×109/L |
Differential count (number fraction) |
||||||
Neutrophils-segmented |
Whole blood |
56 |
% |
0.01 |
0.56 |
Proportion of 1.0 |
Neutrophils-bands |
Whole blood |
3 |
% |
0.01 |
0.03 |
Proportion of 1.0 |
Lymphocytes |
Whole blood |
34 |
% |
0.01 |
0.34 |
Proportion of 1.0 |
Monocytes |
Whole blood |
4 |
% |
0.01 |
0.04 |
Proportion of 1.0 |
Eosinophils |
Whole blood |
2.7 |
% |
0.01 |
0.027 |
Proportion of 1.0 |
Basophils |
Whole blood |
0.3 |
% |
0.01 |
0.003 |
Proportion of 1.0 |
Zidovudine |
Serum, plasma |
0.15-0.27 |
μg/mL |
3.7 |
0.56-1.01 |
μmol/L |
Zinc |
Serum |
75-120 |
μg/dL |
0.153 |
11.5-18.5 |
μmol/L |
a The laboratory values and reference ranges are provided for illustration only and are not intended to be comprehensive or definitive. Each laboratory determines its own values, and reference ranges are highly method dependent. Reference values given are for adults. For some entries for which specific molecular masses are not known (eg, proteins), reference values in SI are given as mass amounts per liter.
The information in this table is adapted from and based on the following sources: (1) Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Laboratory reference values. N Engl J Med. 2004;351(15):1548-1563; (2) Young DS, Huth EJ. SI Units for Clinical Measurement. Philadelphia, PA: American College of Physicians; 1998; (3) Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Philadelphia, PA: WB Saunders; 2001; (4) Kasper DL, Braunwald E, Fauci AS, et al, eds. Harrison’s Principles of Internal Medicine, 16th ed. New York, NY: McGraw Hill; 2004; and (5) Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd ed. Philadelphia, PA: WB Saunders; 2004.
For laboratory values reported in JAMA and in the Archives Journals, factors for converting conventional units to SI units should be provided in the article. In text, the conversion factor should be given once, at first mention of the laboratory value, in parentheses following the conventional unit.
The blood glucose concentration of 126 mg/dL (to convert to millimoles per liter, multiply by 0.055) was used as a criterion for diagnosing diabetes.
For articles in which several laboratory values are reported in text, the conversion factors may be listed in a paragraph at the end of the “Methods” section. For figures or tables, the conversion factors should be included in legends or in footnotes, respectively, but not in the abstract of the article. (See Footnotes in 4.1.3, Visual Presentation of Data, Tables, Table Components.)
Hematologic values should be reported by means of conventional units.
The complete blood cell count showed a hemoglobin level of 13.4 g/dL, hematocrit of 41%, platelet count of 180 000/μL, and white blood cell count of 6500/μL.
For enzymatic activity, the international unit (IU) is used; 1 IU equals the amount of enzyme generating 1 μmol of product per minute.
The peak follicle-stimulating hormone level was 48 mIU/mL.